**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 2454-37-7 |Benzenemethanol, 3-Amino-.Alpha.-Methy| 98 | 219-525-3 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: None Listed.
Risk Phrases: None Listed.
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Light sensitive.The toxicological properties of this material have
not been fully investigated.
Potential Health Effects
Eye:
Causes mild eye irritation. May cause chemical conjunctivitis and
corneal damage.
Skin:
May cause skin irritation. Substance is rapidly absorbed through the
skin. Absorption into the body may cause cyanosis (bluish
discoloration of skin due to deficient oxygenation of the blood).
Ingestion:
May cause irritation of the digestive tract. May cause liver and
kidney damage. Methemoglobinemia is characterized by dizziness,
drowsiness, headache, shortness of breath, cyanosis (bluish
discoloration of skin due to deficient oxygenation of the blood),
rapid heart rate and chocolate-brown colored blood. Overexposure may
cause methemoglobinemia. Ingestion of nitrate containing compounds
can lead to methemoglobinemia.
Inhalation:
May cause respiratory tract irritation. May cause liver and kidney
damage. Methemoglobinemia is characterized by dizziness, drowsiness,
headache, shortness of breath, cyanosis (bluish discoloration of
skin due to deficient oxygenation of the blood), rapid heart rate and
chocolate-brown blood. Inhalation of aniline causes anoxia due to the
formation of methemoglobin.
Chronic:
May cause liver and kidney damage. May cause methemoglobinemia,
which is characterized by chocolate-brown colored blood, headache,
weakness, dizziness, breath shortness, cyanosis (bluish skin due to
deficient oxygenation of blood), rapid heart rate, unconsciousness
and possible death.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15
minutes while removing contaminated clothing and shoes. Wash clothing
before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical
aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and
drink 2-4 cupfuls of milk or water. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not
breathing, give artificial respiration. If breathing is difficult,
give oxygen. Get medical aid.
Notes to Physician:
For methemoglobinemia, administer oxygen alone or with Methylene
Blue depending on the methemoglobin concentration in the blood.
Antidote:
Methylene blue, alone or in combination with oxygen is indicated as
a treatment in nitrite induced methemoglobinemia.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use agent most appropriate to extinguish fire. Use water spray, dry
chemical, carbon dioxide, or appropriate foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal
container. Clean up spills immediately, observing precautions in the
Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Use with adequate ventilation.
Minimize dust generation and accumulation. Avoid contact with eyes,
skin, and clothing. Keep container tightly closed. Avoid ingestion
and inhalation. Store protected from light.
Storage:
Store in a tightly closed container. Store in a cool, dry,
well-ventilated area away from incompatible substances. Store
protected from light.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate
ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 2454-37-7:
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
A respiratory protection program that meets OSHA's 29
CFR 1910.134 and ANSI Z88.2 requirements or European
Standard EN 149 must be followed whenever workplace
conditions warrant respirator use.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Lumps
Color: grey - brown - slightly beige
Odor: aniline-like
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: 217 deg C
Freezing/Melting Point: 68 - 71 deg C
Autoignition Temperature: Not applicable.
Flash Point: 157 deg C ( 314.60 deg F)
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water: soluble in water
Specific Gravity/Density:
Molecular Formula: C8H11NO
Molecular Weight: 137.18
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable at room temperature in closed containers under normal storage
and handling conditions.
Conditions to Avoid:
Incompatible materials, light, dust generation, excess heat.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, irritating and toxic fumes and
gases, carbon dioxide, ammonia.
Hazardous Polymerization: Has not been reported.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 2454-37-7: DN5600000
LD50/LC50:
CAS# 2454-37-7: Oral, rat: LD50 = 3100 mg/kg; Skin, rabbit: LD50 =
3560 uL/kg.
Carcinogenicity:
Benzenemethanol, 3-Amino-.Alpha.-Methyl- -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
S 28A After contact with skin, wash immediately with
plenty of water.
S 37 Wear suitable gloves.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 2454-37-7: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 2454-37-7 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 2454-37-7 is not listed on the TSCA inventory.
It is for research and development use only.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 9/02/1997 Revision #6 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
(R)-(-)-sec-Butanol, 99%
| 78-92-2 |
|
4-Acetamidobenzoic acid
| 556-08-1 |
|
5,6-Dimethyl-1H-Benzotriazole Hydrate, 99%
| 4184-79-6 |
|
Alpha-Methyl-1-Piperidineethanol, 97%
| 934-90-7 |
|
3-Bromobenzyl Bromide, 95%
| 823-78-9 |
|
d-(-)-Quinic acid, 98%
| 77-95-2 |
|
3-(Chlorosulfonyl)benzoyl Chloride, 98% (Titr.)
| 4052-92-0 |
|
3-Chloro-4-Hydroxyphenylacetic Acid 99%
| 33697-81-3 |
|
n-Tosyl-3-pyrrolecarboxylic acid, 96%
| 106058-86-0 |
|
Methylenedithiocyanate, 98%
| 6317-18-6 |
|
Tri-n-butylphosphine, 95%
| 998-40-3 |
|
Neocuproine, 99%
| 484-11-7 |
|
M-Tolylurea, 96%
| 63-99-0 |
|
Nonadecanol, 99+%
| 1454-84-8 |
|
Lithium sulfate, anhydrous, 99%
| 10377-48-7 |
|
6-Acetamidohexanoic Acid, 99%
| 57-08-9 |
|
5,5-Dimethyloxazolidine-2,4-Dione, 99%
| 695-53-4 |
|
Tetramethylammonium nitrate
| 1941-24-8 |
|
1,2:5,6-Di-O-Cyclohexylidene-Alpha-D-Gluco Furanose, 96%
| 23397-76-4 |
|
Ethyl benzoylacetate, 97%
| 94-02-0 |
|
3-(1-Hydroxyethyl)aniline, 98%
| 2454-37-7 |
|
2-Deoxy-D-Glucose, 99%
| 154-17-6 |
|
1-Pyrrolidino-1-cyclopentene, 98%
| 7148-07-4 |
|
1,1',3,3,3',3'-Hexamethylindodicarbocyanine iodide, laser grade, 99%
| 36536-22-8 |
|
3-Amino-5-methylthio-1h-1,2,4-triazole
| 45534-08-5 |
|
Triptycene, 99% (HPLC)
| 477-75-8 |
|
2-Bromoanisole, 97%
| 578-57-4 |
|
2-Phenylphenol, 99+%
| 90-43-7 |
|
3-Acetylthiophene, 98%
| 1468-83-3 |
|
2,5-Diphenyl-1,3,4-oxadiazole, 97%
| 725-12-2 |
|
(D,L)-1-Aminoethylphosphonic Acid, 97%
| 6323-97-3 |
|
2,3,5,6-Tetrafluoroaniline, 98%
| 700-17-4 |
|
4'-Nitroacetanilide (Pract)
| 104-04-1 |
|
4-Aminobenzophenone, 98%
| 1137-41-3 |
|
3-Acetylbenzenesulfonyl fluoride, 99%
| 709-60-4 |
|
1,2:5,6-Di-O-Cyclohexylidene-3-O-Methyl-Alpha-D-Glucofuranose, 98%
| 13440-19-2 |
|
Potassium tetrachloroplatinate(II)
| 10025-99-7 |
|
Diethyl Benzylphosphonate, 99%
| 1080-32-6 |
|
4-Aminophthalimide, 97% (UV-Vis)
| 3676-85-5 |
|
1-Heptanesulfonic acid sodium salt pre- mixed concentrate
| 0-00-0 |
|
4-(2-Aminoethyl)-Benzenesulfonamide Monohydrochloride, 99+%
| 42286-14-6 |
|
Tetraheptylammonium Bromide, 99%
| 4368-51-8 |
|
Methyl Valerate, 99% (GC)
| 624-24-8 |
|
Duolite c 206a
| |
|
4'-Aminoacetophenone, 99%
| 99-92-3 |
|
Ricinoleic Acid (Pract), 85% Castor Oil Fatty Acid
| 141-22-0 |
|
3-Chlorobenzyl Chloride, 98%
| 620-20-2 |
|
Carbonyl Cyanide M-Chlorophenylhydrazone, 99+%
| 555-60-2 |
|
1,3-Dimethyladamantane, 99+%
| 702-79-4 |
|
Dl-1,4-dibromo-2,3-butanediol,95%
| 299-70-7 |
|
|